Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Arthritis Research & Therapy|November 24, 2017
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registryGerd Horneff, Anna Carina Schulz, Jens Klotsche, et al.
The Journal of Pediatrics|December 17, 2017
Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic ArthritisSandra Schenck, Joachim Rosenbauer, Martina Niewerth, et al.
Arthritis Research & Therapy|October 30, 2020
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registryGiulia Armaroli, Ariane Klein, Gerd Ganser, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 18, 2022
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With BiologicsIlse J Broekaert, Ariane Klein, Daniel Windschall, et al.
Arthritis Research & Therapy|December 15, 2018
Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohortClaudia Sengler, Julian Zink, Jens Klotsche, et al.
RMD Open|April 9, 2026
Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICONPrasad T Oommen, Jens Klotsche, Rainer Berendes, et al.
ACR Open Rheumatology|January 17, 2020
Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER RegistryAriane Klein, Ingrid Becker, Kirsten Minden, et al.
Pediatric Rheumatology Online Journal|April 18, 2024
Risk perception, well-being, depression and anxiety in children and adolescents with rheumatic diseases during the COVID-19 pandemic - results from the prospective multicenter KICK-COVID study in GermanyClaudia Sengler, Jens Klotsche, Malthe Jessen Pedersen, et al.
Rheumatology International|April 12, 2018
The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Dirk Holzinger, Dirk Foell, Gerd Horneff, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and AustriaClaas H Hinze, Prasad T Oommen, Frank Dressler, et al.
Pageof 4